Clinical Approach to Ataxia
Pediatric Neurology Framework1. Symptom Overview
Understanding the clinical significance and classification of ataxia in children
Ataxia in children represents a significant diagnostic challenge, accounting for approximately 1-2% of pediatric neurology consultations. Acute ataxia is the most common presentation, with acute cerebellar ataxia (post-infectious) being the leading cause in children aged 2-7 years, representing approximately 30-50% of acute cases. The annual incidence of acute ataxia in children is estimated at 1-3 per 100,000 children. Chronic and progressive ataxias, while less common, are often associated with serious underlying conditions including posterior fossa tumors (which account for approximately 50% of pediatric brain tumors) and inherited metabolic or degenerative disorders.
Definition
Ataxia is a neurological sign characterized by impaired coordination of voluntary movements without weakness, resulting from dysfunction of the cerebellum, its afferent or efferent connections, or the sensory pathways responsible for proprioception. In children, it manifests as unsteady gait, poor balance, intention tremor, dysmetria, and difficulties with fine motor tasks. The term derives from the Greek “a-taxis” meaning “without order.”
Key Epidemiology
- Acute cerebellar ataxia: Most common cause in children aged 2-7 years (30-50% of acute cases)
- Drug or toxin ingestion: Second most common cause of acute ataxia in young children
- Posterior fossa tumors: Account for 50% of pediatric brain tumors; present with ataxia in 60-80%
- Inherited ataxias: Prevalence of 1-9 per 100,000 depending on type and population
- Peak age for acute cerebellar ataxia: 2-4 years old
Classification by Duration
Duration of symptoms is the most critical initial classification, as it guides the urgency of evaluation and narrows the differential diagnosis significantly.
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Less than 72 hours | Acute cerebellar ataxia, drug or toxin ingestion, stroke, acute disseminated encephalomyelitis, labyrinthitis | Requires urgent evaluation to exclude life-threatening causes; most common presentation in children |
| Subacute | 72 hours to 4 weeks | Posterior fossa tumor, abscess, Miller Fisher syndrome, opsoclonus-myoclonus syndrome | High index of suspicion for structural lesions; neuroimaging essential |
| Chronic Non-Progressive | Greater than 4 weeks, stable | Cerebral palsy (ataxic type), congenital malformations (Dandy-Walker, Joubert syndrome), sequelae of prior injury | Often congenital or early-onset; focus on rehabilitation and functional optimization |
| Chronic Progressive | Greater than 4 weeks, worsening | Hereditary ataxias (Friedreich ataxia, ataxia-telangiectasia), metabolic disorders, slow-growing tumors | Suggests degenerative or metabolic etiology; genetic and metabolic workup indicated |
| Episodic | Recurrent episodes with complete recovery | Episodic ataxias (types 1 and 2), basilar migraine, metabolic disorders (maple syrup urine disease variants) | Often genetic; ion channelopathies common; may respond to specific treatments |
Classification by Type
Understanding the anatomical basis of ataxia helps localize the lesion and guide the diagnostic approach.
Cerebellar Ataxia
Most common type in children
Features: Wide-based gait, intention tremor, dysmetria, dysdiadochokinesia, nystagmus, dysarthria (scanning speech)
Key point: Not corrected by visual input; Romberg test typically negative or minimally positive
Sensory Ataxia
Less common in children
Features: High-stepping gait, positive Romberg sign, loss of proprioception and vibration sense, pseudoathetosis
Key point: Worsens with eyes closed; suggests posterior column or peripheral nerve involvement
Vestibular Ataxia
Often misdiagnosed initially
Features: Veering or falling to one side, vertigo, nausea, nystagmus (horizontal or rotatory)
Key point: Directional tendency; associated with vestibular symptoms; may be peripheral or central
Classification by Associated Features
| Pattern | Associated Features | Suggests |
|---|---|---|
| Ataxia with altered consciousness | Lethargy, confusion, seizures, vomiting | Intoxication, encephalitis, increased intracranial pressure, metabolic crisis |
| Ataxia with fever | Preceding or concurrent febrile illness | Post-infectious cerebellar ataxia, meningitis, encephalitis, cerebellar abscess |
| Ataxia with headache and vomiting | Morning headache, projectile vomiting, papilledema | Posterior fossa tumor, hydrocephalus, intracranial hemorrhage |
| Ataxia with opsoclonus-myoclonus | Chaotic eye movements, myoclonic jerks, irritability | Opsoclonus-myoclonus syndrome (may be paraneoplastic—neuroblastoma) |
| Ataxia with peripheral neuropathy | Areflexia, sensory loss, weakness | Friedreich ataxia, Miller Fisher syndrome, vitamin deficiencies |
| Ataxia with oculomotor abnormalities | Apraxia of eye movements, telangiectasias | Ataxia-telangiectasia, spinocerebellar ataxias |
| Ataxia with developmental regression | Loss of previously acquired skills | Metabolic disorders, mitochondrial disease, leukodystrophies |
Age-Specific Considerations
| Age Group | Most Common Causes | Special Considerations |
|---|---|---|
| Infant (0-12 months) | Congenital malformations (Dandy-Walker, Joubert syndrome), hypoxic-ischemic injury, metabolic disorders, neuroblastoma (opsoclonus-myoclonus) | Ataxia may be difficult to recognize; presents as hypotonia, delayed motor milestones, abnormal reaching |
| Toddler (1-3 years) | Acute cerebellar ataxia, drug or toxin ingestion, posterior fossa tumors, neuroblastoma | Peak age for acute cerebellar ataxia; always consider accidental ingestion; opsoclonus-myoclonus often presents in this age |
| Preschool (3-5 years) | Acute cerebellar ataxia, posterior fossa tumors, acute disseminated encephalomyelitis | Can provide history; tumors become more common; consider ADEM especially with encephalopathy |
| School Age (6-12 years) | Posterior fossa tumors, Friedreich ataxia onset, migraine variants, conversion disorder | Hereditary ataxias often manifest; functional disorders increase; more reliable examination |
| Adolescent (12-18 years) | Friedreich ataxia, spinocerebellar ataxias, multiple sclerosis, drug or alcohol ingestion, functional ataxia | Adult-pattern causes emerge; consider intentional substance use; psychological factors important |
Key Concept: The “Big Four” Causes of Acute Ataxia in Children
In a child presenting with acute ataxia, four diagnoses account for the vast majority of cases:
- Acute cerebellar ataxia (post-infectious) — most common, typically ages 2-7
- Drug or toxin ingestion — always consider, especially in toddlers
- Posterior fossa tumor — must be excluded with imaging
- Acute disseminated encephalomyelitis — especially with encephalopathy
A systematic approach addressing these four entities will capture the majority of acute presentations while ensuring life-threatening conditions are not missed.
2. Pathophysiology and Mechanisms
Understanding the neural basis and mechanisms of ataxia in children
Coordinated movement requires the seamless integration of multiple neural systems. The cerebellum serves as the primary coordinator, receiving input from sensory systems (proprioception, vestibular, visual) and motor cortex, then modulating motor output to produce smooth, accurate movements. Ataxia results from disruption anywhere along these pathways—whether in the cerebellum itself, its afferent inputs, efferent outputs, or the sensory systems that inform movement planning.
The Cerebellar System: Anatomy and Function
| Cerebellar Region | Input Sources | Function | Dysfunction Produces |
|---|---|---|---|
| Vestibulocerebellum (Flocculonodular lobe) | Vestibular nuclei, visual input | Balance and eye movement coordination | Truncal ataxia, nystagmus, vertigo, impaired vestibulo-ocular reflex |
| Spinocerebellum (Vermis and paravermis) | Spinal cord (proprioception), trigeminal nuclei | Posture, gait, and proximal limb coordination | Gait ataxia, truncal instability, titubation |
| Cerebrocerebellum (Lateral hemispheres) | Cerebral cortex (via pontine nuclei) | Planning and fine-tuning of voluntary limb movements | Limb ataxia, dysmetria, intention tremor, dysdiadochokinesia |
Neural Pathways Involved in Coordination
| Pathway Component | Structures Involved | Function | Lesion Effect |
|---|---|---|---|
| Afferent (Input) | Spinocerebellar tracts, vestibular system, pontocerebellar fibers | Convey proprioceptive, vestibular, and cortical information to cerebellum | Sensory ataxia, impaired error correction |
| Integration | Cerebellar cortex (Purkinje cells), deep cerebellar nuclei | Compare intended versus actual movement, generate corrective signals | Cerebellar ataxia with all classic features |
| Efferent (Output) | Superior cerebellar peduncle, red nucleus, thalamus, motor cortex | Transmit corrective signals to motor systems | Intention tremor, dysmetria |
| Sensory Feedback | Posterior columns (proprioception), peripheral nerves | Provide real-time position sense for movement adjustment | Sensory ataxia, positive Romberg sign |
Mechanisms of Cerebellar Signs
Dysmetria
Mechanism: The cerebellum calculates the trajectory and force needed for accurate movement. Cerebellar dysfunction causes errors in these calculations, resulting in over-shooting (hypermetria) or under-shooting (hypometria) of targets.
Clinical test: Finger-to-nose, heel-to-shin testing
Intention Tremor
Mechanism: Failure of the cerebellum to dampen oscillations in movement as the limb approaches a target. The tremor worsens with visually guided movements and increases near the target.
Clinical test: Observe tremor amplitude increase during finger-to-nose test
Dysdiadochokinesia
Mechanism: Impaired timing and coordination of rapidly alternating movements due to failure of the cerebellum to smoothly sequence agonist-antagonist muscle activation.
Clinical test: Rapid alternating movements (pronation-supination)
Ataxic Gait
Mechanism: Impaired integration of postural adjustments with locomotion. The vermis coordinates axial muscles for balance, and hemispheres coordinate limb placement. Dysfunction produces wide-based, unsteady gait.
Clinical test: Observe gait, tandem walking
Pathophysiology by Condition
| Condition | Pathophysiological Mechanism | Clinical Implication |
|---|---|---|
| Acute cerebellar ataxia (post-infectious) | Autoimmune-mediated inflammation of cerebellum following viral infection (varicella, Epstein-Barr virus, enteroviruses). Molecular mimicry between viral antigens and cerebellar proteins triggers immune attack on Purkinje cells and cerebellar white matter. | Self-limited course in most cases; symptoms resolve as inflammation subsides; typically no permanent damage; excellent prognosis |
| Drug and toxin-induced ataxia | Direct toxic effects on cerebellar neurons (alcohol, anticonvulsants, benzodiazepines) or vestibular system. Mechanisms include: GABA receptor modulation, mitochondrial dysfunction, oxidative stress, and ion channel interference. | Usually reversible with toxin removal; degree of recovery depends on exposure duration and agent; some toxins (lead, mercury) may cause permanent damage |
| Posterior fossa tumors | Mass effect causes direct compression or infiltration of cerebellar tissue. Associated hydrocephalus from fourth ventricle obstruction contributes to symptoms. Edema around tumor extends functional damage. | Requires surgical intervention; ataxia may improve with tumor resection and hydrocephalus treatment; residual deficits depend on extent of cerebellar damage |
| Acute disseminated encephalomyelitis | Post-infectious or post-vaccination autoimmune demyelination affecting multiple central nervous system regions including cerebellar white matter and peduncles. T-cell mediated attack on myelin. | Responds to immunotherapy (corticosteroids, intravenous immunoglobulin); most children recover well; some have residual deficits or recurrence |
| Friedreich ataxia | GAA trinucleotide repeat expansion in FXN gene causes frataxin deficiency. Frataxin is essential for mitochondrial iron-sulfur cluster assembly. Deficiency leads to mitochondrial dysfunction, oxidative stress, and degeneration of spinocerebellar tracts, posterior columns, and dorsal root ganglia. | Progressive course; combined cerebellar and sensory ataxia; cardiomyopathy develops; no cure but emerging therapies target frataxin restoration |
| Ataxia-telangiectasia | Mutations in ATM gene impair DNA double-strand break repair. Cerebellar Purkinje cells and granule cells are particularly vulnerable to DNA damage and progressively degenerate. Associated immunodeficiency and cancer predisposition from same mechanism. | Progressive cerebellar degeneration; multisystem involvement; elevated alpha-fetoprotein; avoid radiation exposure due to radiosensitivity |
| Episodic ataxia type 2 | Mutations in CACNA1A gene encoding P/Q-type calcium channel. Abnormal calcium channel function in cerebellar Purkinje cells causes episodic dysfunction triggered by stress, exertion, or caffeine. May develop progressive baseline ataxia. | Episodes may respond to acetazolamide; identifies channelopathy family; some develop progressive ataxia between episodes |
| Opsoclonus-myoclonus syndrome | Autoimmune attack on cerebellar and brainstem neurons, often paraneoplastic (neuroblastoma in 50% of pediatric cases). Antibodies against neural antigens cause widespread cerebellar and brainstem dysfunction. | Must search for occult neuroblastoma; immunotherapy often needed long-term; neurodevelopmental sequelae common despite treatment |
| Miller Fisher syndrome | Post-infectious autoimmune polyneuropathy (Guillain-Barré spectrum). Anti-GQ1b antibodies target oculomotor nerves, proprioceptive neurons, and cerebellar input pathways causing ataxia, ophthalmoplegia, and areflexia. | Triad of ataxia, ophthalmoplegia, areflexia; usually self-limited; intravenous immunoglobulin may hasten recovery |
Developmental Considerations in Pediatric Ataxia
The immature nervous system presents unique considerations in pediatric ataxia. The cerebellum undergoes significant postnatal development, with Purkinje cell maturation and synaptogenesis continuing through early childhood. This developmental plasticity has implications for both vulnerability and recovery.
Vulnerability Factors
- Purkinje cell sensitivity: These large neurons have high metabolic demands and are particularly vulnerable to hypoxia, toxins, and autoimmune attack
- Ongoing myelination: Cerebellar white matter myelination continues postnatally, making it susceptible to demyelinating processes
- Blood-brain barrier immaturity: May allow greater entry of toxins and immune mediators in young children
Recovery Factors
- Neuroplasticity: The immature brain has greater capacity for reorganization and compensation
- Cerebellar reserve: Redundancy in cerebellar circuits may allow functional recovery if damage is incomplete
- Developmental timing: Earlier injury may allow more complete compensation through alternative pathway development
Often Overlooked Mechanism: Cerebellar Cognitive Affective Syndrome
The cerebellum is not purely a motor structure. Cerebellar lesions, particularly in children, can cause cognitive and behavioral changes including executive dysfunction, impaired spatial cognition, language difficulties, and emotional dysregulation. This “cerebellar cognitive affective syndrome” is increasingly recognized and may explain behavioral changes accompanying pediatric cerebellar disorders. The posterior vermis and lateral hemispheres have particularly strong connections to limbic and prefrontal regions. Always assess cognition and behavior in children with cerebellar pathology.
Distinguishing Cerebellar from Sensory Ataxia
| Feature | Cerebellar Ataxia | Sensory Ataxia |
|---|---|---|
| Effect of vision | Minimal effect; ataxia present with eyes open | Markedly worse with eyes closed (positive Romberg) |
| Romberg sign | Negative or minimally positive | Strongly positive |
| Gait pattern | Wide-based, lurching, irregular | High-stepping, “stomping,” watches feet |
| Proprioception | Normal | Impaired (abnormal joint position sense) |
| Vibration sense | Normal | Often impaired |
| Deep tendon reflexes | Normal or pendular (hyporeflexia rare) | Often absent (especially in peripheral neuropathy) |
| Nystagmus | Common (cerebellar-type) | Absent |
| Speech | Dysarthric (scanning, slurred) | Normal |
| Pseudoathetosis | Absent | Present (wandering fingers with eyes closed) |
Mixed Ataxia Syndromes
Some conditions produce both cerebellar and sensory ataxia simultaneously. Friedreich ataxia is the classic example, with degeneration of both spinocerebellar tracts (cerebellar input) and posterior columns (sensory). This produces a mixed clinical picture with features of both ataxia types. The combination of cerebellar signs with areflexia and sensory loss should prompt consideration of Friedreich ataxia in a child with progressive ataxia.
3. History Taking
A comprehensive approach to eliciting the ataxia history in children
Red Flags — Require Urgent Evaluation
- Altered consciousness — Encephalitis, intoxication, raised intracranial pressure
- Severe headache with vomiting — Posterior fossa tumor, hemorrhage, hydrocephalus
- Papilledema or bulging fontanelle — Raised intracranial pressure requiring urgent imaging
- Neck stiffness with fever — Meningitis, cerebellar abscess
- Focal neurological deficits — Stroke, tumor, demyelination
- Rapidly progressive weakness — Guillain-Barré syndrome, Miller Fisher syndrome
- Acute onset with witnessed trauma — Intracranial hemorrhage, cervical spine injury
- Opsoclonus (chaotic eye movements) — Opsoclonus-myoclonus syndrome, search for neuroblastoma
- Signs of raised intracranial pressure — Cushing triad, sixth nerve palsy
- Suspected ingestion with respiratory depression — Toxic ingestion requiring immediate intervention
- Hemiparesis or asymmetric findings — Stroke, tumor, abscess
- Developmental regression — Metabolic crisis, progressive neurodegeneration
Systematic History: The “WOBBLE” Approach
Use the mnemonic “WOBBLE” to ensure comprehensive history taking for pediatric ataxia:
- W — When and What: When did it start? What were the first symptoms? Acute, gradual, or episodic onset?
- O — Other Symptoms: Associated symptoms—headache, vomiting, fever, vision changes, weakness, sensory changes, behavioral changes?
- B — Before This: Any preceding illness, vaccination, trauma, or medication changes? Recent febrile illness (especially varicella)?
- B — Background: Birth history, developmental milestones, immunizations, previous neurological problems, family history of ataxia or neurological disease?
- L — Look for Toxins: Access to medications, household chemicals, alcohol, drugs of abuse? Any possibility of accidental or intentional ingestion?
- E — Evolution: How has it changed? Getting better, worse, or fluctuating? Any episodes of complete recovery?
Characterizing the Onset
| Onset Pattern | Typical Timeframe | Suggests | Key Questions |
|---|---|---|---|
| Hyperacute | Seconds to minutes | Stroke, hemorrhage, trauma, seizure | “Was the child completely normal one moment and then suddenly unsteady?” |
| Acute | Hours to days | Acute cerebellar ataxia, intoxication, acute disseminated encephalomyelitis, infection | “Over how many hours or days did this develop? Was the child ill recently?” |
| Subacute | Days to weeks | Tumor, abscess, Miller Fisher syndrome, opsoclonus-myoclonus syndrome | “Has this been getting slowly worse over days to weeks?” |
| Chronic progressive | Months to years | Hereditary ataxias, metabolic disorders, slow-growing tumors | “When did you first notice something was different? Has coordination been gradually declining?” |
| Episodic | Recurrent discrete episodes | Episodic ataxias, basilar migraine, metabolic disorders | “Does the unsteadiness come and go completely? How long do episodes last?” |
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Acute cerebellar ataxia (post-infectious) | Preceding viral illness (especially varicella), age 2-7 years, no altered consciousness | “Did your child have chickenpox, a cold, or stomach bug in the past 1-3 weeks? Has the child been vaccinated recently?” |
| Drug or toxin ingestion | Acute onset, altered consciousness possible, toddler age group | “Could your child have gotten into any medications, alcohol, cleaning products, or plants? Are there older siblings or grandparents with medications at home?” |
| Posterior fossa tumor | Subacute progressive course, morning headache and vomiting, personality changes | “Has your child had headaches, especially in the morning? Any vomiting, particularly on waking? Have you noticed any changes in personality or school performance?” |
| Acute disseminated encephalomyelitis | Post-infectious, encephalopathy, multifocal symptoms | “Besides the unsteadiness, has your child been confused, unusually sleepy, or behaving differently? Any recent illness or vaccination?” |
| Opsoclonus-myoclonus syndrome | Chaotic eye movements, myoclonic jerks, irritability | “Have you noticed unusual eye movements—do the eyes seem to dance or jump around? Does your child have jerky movements or seem unusually irritable?” |
| Friedreich ataxia | Progressive gait ataxia, onset typically 5-15 years, scoliosis, foot deformities | “Has the clumsiness been getting worse over months or years? Does anyone else in the family have balance problems or need a wheelchair? Has your child developed scoliosis or foot problems?” |
| Ataxia-telangiectasia | Progressive ataxia, recurrent sinopulmonary infections, telangiectasias | “Does your child get frequent sinus infections or pneumonia? Have you noticed any red lines or spots on the eyes or skin?” |
| Episodic ataxia | Recurrent episodes with triggers, complete recovery between | “Do episodes happen after stress, exercise, or being startled? Is your child completely normal between episodes? Does anyone in the family have similar spells or migraines?” |
| Miller Fisher syndrome | Preceding infection, areflexia, ophthalmoplegia | “Has your child had double vision or drooping eyelids? Was there a respiratory or gastrointestinal illness in the past few weeks?” |
| Basilar migraine | Episodic, associated headache, visual symptoms, vertigo, family history | “Does your child get headaches with the unsteadiness? Any visual changes like flashing lights or blind spots? Family history of migraines?” |
| Labyrinthitis or vestibular neuritis | Acute vertigo, nausea, nystagmus, recent upper respiratory infection | “Does your child feel like the room is spinning? Is there severe nausea? Recent ear infection or cold?” |
| Functional ataxia | Inconsistent examination, distractibility, psychosocial stressors | “How is school going? Any stressors at home or with friends? Does the unsteadiness seem better when distracted?” |
Pediatric-Specific History Components
Birth and Developmental History
- Pregnancy: Infections, exposures, complications
- Delivery: Gestational age, mode of delivery, complications
- Perinatal: Apgar scores, NICU stay, hypoxic-ischemic events, neonatal seizures
- Gross motor milestones: Head control (3 months), sitting (6 months), walking (12 months)
- Fine motor milestones: Reaching, grasping, pincer grip
- Language milestones: Babbling, first words, sentences
- Any regression: Loss of previously acquired skills (critical red flag)
Family History
- Consanguinity: Increases risk of autosomal recessive conditions (Friedreich ataxia, ataxia-telangiectasia)
- Ataxia or gait problems: Hereditary ataxias
- Early death or wheelchair use: Progressive neurological disease
- Cardiomyopathy: Associated with Friedreich ataxia
- Migraines: Episodic ataxias, basilar migraine
- Cancers: Ataxia-telangiectasia families have increased cancer risk
- Autoimmune diseases: May suggest autoimmune etiology
Immunization and Infection History
- Immunization status: Up to date? Recent vaccinations?
- Varicella: Either natural infection or vaccination (associated with acute cerebellar ataxia)
- Recent infections: Upper respiratory infection, gastroenteritis, Epstein-Barr virus, Mycoplasma
- Recurrent infections: May suggest immunodeficiency (ataxia-telangiectasia)
Medication and Toxin Exposure
- Current medications: Anticonvulsants (phenytoin, carbamazepine), benzodiazepines, antihistamines
- Access to medications: Grandparents’ medications, older siblings’ medications
- Household chemicals: Cleaning products, pesticides, alcohol
- Lead exposure: Old paint, contaminated water, imported items
- In adolescents: Alcohol, cannabis, other substances
Medications and Substances That Cause Ataxia
| Category | Specific Agents | Mechanism | Clinical Clues |
|---|---|---|---|
| Anticonvulsants | Phenytoin, carbamazepine, phenobarbital, valproate, gabapentin | Cerebellar toxicity, ion channel effects | Check drug levels; phenytoin may cause permanent cerebellar damage with chronic toxicity |
| Sedatives and hypnotics | Benzodiazepines, barbiturates, antihistamines, sleep aids | GABA receptor modulation, central nervous system depression | Drowsiness, slurred speech; often accidental ingestion in toddlers |
| Alcohol | Ethanol | GABA enhancement, glutamate inhibition, direct cerebellar toxicity | Breath odor, behavioral changes; consider in adolescents |
| Antivertigo and antiemetics | Meclizine, prochlorperazine | Vestibular suppression, anticholinergic effects | May have been given for initial symptoms of vestibular disorder |
| Heavy metals | Lead, mercury, thallium | Neurotoxicity, peripheral neuropathy, cerebellar damage | Chronic exposure; check environmental history; may have other symptoms |
| Chemotherapeutics | Cytarabine, 5-fluorouracil, methotrexate | Direct cerebellar toxicity | Relevant in children with cancer; onset during or after treatment |
| Cannabis and synthetic cannabinoids | THC, K2, Spice | Cannabinoid receptor effects | Consider in adolescents; synthetic cannabinoids unpredictable |
History Taking Pearl: The Collateral Historian
In pediatric ataxia, the parent or caregiver is your primary historian, but don’t forget to also observe and speak directly with the child when age-appropriate. Children may reveal information about ingestions, trauma, or symptoms that caregivers aren’t aware of. In adolescents, consider interviewing privately about substance use. Additionally, ask if there are videos of the child’s normal gait for comparison, or if they can show you how the ataxia looks during episodes (for episodic ataxias). Teachers and school nurses may provide valuable observations about school performance changes or witnessed events.
4. Physical Examination
A systematic neurological approach for the ataxic child
Systematic Framework: The examination of the ataxic child should be comprehensive, focusing on neurological assessment while also seeking clues to underlying systemic conditions. Use an age-appropriate approach—examination techniques must be adapted for infants, toddlers, and older children.
General Inspection
- Level of consciousness: Alert, drowsy, confused, obtunded (altered consciousness suggests intoxication, encephalitis, raised intracranial pressure)
- General appearance: Well or unwell appearing, signs of distress
- Nutritional status: Failure to thrive may suggest chronic illness, metabolic disorder
- Dysmorphic features: May suggest syndromic cause (Joubert syndrome facial features, ataxia-telangiectasia features)
- Skin findings: Telangiectasias (ataxia-telangiectasia), café-au-lait spots (neurofibromatosis), neurocutaneous markers
- Posture: Scoliosis (Friedreich ataxia), kyphosis, truncal instability
- Spontaneous movements: Myoclonus (opsoclonus-myoclonus syndrome), tremor, abnormal movements
Vital Signs
| Age | Heart Rate (bpm) | Respiratory Rate (/min) | Systolic BP (mmHg) | Ataxia-Relevant Considerations |
|---|---|---|---|---|
| Infant (0-12 months) | 100-160 | 30-60 | 70-100 | Bradycardia with hypertension suggests raised intracranial pressure (Cushing response) |
| Toddler (1-3 years) | 90-150 | 24-40 | 80-110 | Tachycardia with intoxication; check temperature for infection |
| Preschool (3-5 years) | 80-140 | 22-34 | 80-110 | Hypertension may indicate neuroblastoma (catecholamine secretion) |
| School age (6-12 years) | 70-120 | 18-30 | 90-120 | Orthostatic changes may be present in Friedreich ataxia |
| Adolescent (12-18 years) | 60-100 | 12-20 | 100-120 | Similar to adult; check for intoxication, postural hypotension |
Growth Parameters
- Weight, height, head circumference: Plot on appropriate growth charts
- Macrocephaly: May suggest hydrocephalus, megalencephalic conditions
- Microcephaly: May suggest underlying brain malformation, genetic syndrome
- Failure to thrive: Consider metabolic disorders, chronic illness, malignancy
Head and Neck Examination
Head
- Fontanelle (infants): Bulging suggests raised intracranial pressure
- Head circumference: Rapidly increasing suggests hydrocephalus
- Venous distension: May indicate raised intracranial pressure
- Signs of trauma: Bruising, hematoma
Neck
- Neck stiffness: Meningitis, posterior fossa lesion
- Head tilt: Posterior fossa tumor, fourth nerve palsy
- Cervical lymphadenopathy: Infection, malignancy
Eye Examination
| Finding | Description | Clinical Significance |
|---|---|---|
| Papilledema | Optic disc swelling with blurred margins, venous engorgement | Raised intracranial pressure—urgent imaging required |
| Conjunctival telangiectasias | Dilated blood vessels on bulbar conjunctiva | Ataxia-telangiectasia (usually appear age 3-6 years) |
| Opsoclonus | Chaotic, multidirectional saccades (“dancing eyes”) | Opsoclonus-myoclonus syndrome—search for neuroblastoma |
| Cerebellar nystagmus | Gaze-evoked, direction-changing, or downbeat nystagmus | Cerebellar or brainstem lesion |
| Sixth nerve palsy | Inability to abduct the eye, esotropia | False localizing sign of raised intracranial pressure |
| Ophthalmoplegia | Limitation of eye movements, diplopia | Miller Fisher syndrome, brainstem lesion |
| Oculomotor apraxia | Inability to initiate voluntary saccades; uses head thrust | Ataxia-telangiectasia, ataxia with oculomotor apraxia types 1 and 2 |
| Kayser-Fleischer rings | Golden-brown rings at corneal limbus (slit lamp exam) | Wilson disease |
| Pupillary abnormalities | Unequal pupils, sluggish response | Brainstem lesion, herniation, drug effect |
Cerebellar Examination
The cerebellar examination should assess coordination, balance, and motor timing. Techniques must be adapted for the child’s age and developmental level.
Gait Assessment
| Test | Age Appropriate | Technique | Abnormal Finding |
|---|---|---|---|
| Observation of walking | All ambulatory children | Watch child walk naturally across the room; observe base of gait, arm swing, steadiness | Wide-based gait, lurching, unsteadiness, reduced arm swing |
| Tandem gait (heel-to-toe) | ≥4 years (with cooperation) | Walk in a straight line placing heel to toe | Unable to maintain balance, stepping off line, falling |
| Running | ≥3 years | Have child run short distance | Exaggerated unsteadiness, falling, inability to run |
| Hopping | ≥5 years | Hop on each foot separately | Unable to hop, marked asymmetry |
| Romberg test | ≥4 years | Stand with feet together, eyes open then closed | Markedly worse with eyes closed = sensory ataxia; unsteady even with eyes open = cerebellar ataxia |
Limb Coordination Tests
| Test | Age Appropriate | Technique | Abnormal Finding |
|---|---|---|---|
| Finger-to-nose test | ≥3 years | Touch examiner’s finger then own nose, repeatedly | Dysmetria (overshooting or undershooting), intention tremor (worse approaching target) |
| Finger pursuit | ≥2 years | Child follows and touches examiner’s moving finger | Inaccurate tracking, past-pointing |
| Heel-to-shin test | ≥5 years | Run heel smoothly down opposite shin from knee to ankle | Jerky movement, inability to stay on shin, overshooting |
| Rapid alternating movements | ≥5 years | Rapidly alternate pronation and supination of hands on thighs | Dysdiadochokinesia (irregular rhythm, imprecise movements) |
| Reaching for objects | Infants and toddlers | Observe reaching for toys, feeding | Overshooting, tremor when approaching object, difficulty grasping |
Speech Assessment
- Cerebellar dysarthria: “Scanning” speech—irregular, explosive, with abnormal pauses and emphasis
- Ask to repeat: “British constitution” or “Methodist Episcopal”
- In young children: Listen to spontaneous speech for slurring, irregular rhythm
Extended Neurological Examination
Cranial Nerves
| Cranial Nerve | Test | Significance in Ataxia |
|---|---|---|
| II (Optic) | Visual acuity, visual fields, fundoscopy | Papilledema indicates raised intracranial pressure |
| III, IV, VI (Oculomotor) | Eye movements, pupils | Ophthalmoplegia (Miller Fisher), sixth nerve palsy (raised intracranial pressure), oculomotor apraxia (ataxia-telangiectasia) |
| V (Trigeminal) | Facial sensation, corneal reflex | May be affected in brainstem lesions |
| VII (Facial) | Facial symmetry, movements | Facial weakness in posterior fossa lesions, Guillain-Barré spectrum |
| VIII (Vestibulocochlear) | Hearing, vestibular function, nystagmus | Central versus peripheral vestibular dysfunction; hearing loss in some hereditary ataxias |
| IX, X (Glossopharyngeal, Vagus) | Gag reflex, palate movement, swallowing | Bulbar dysfunction in brainstem lesions |
| XII (Hypoglossal) | Tongue movement | Affected in brainstem lesions |
Motor Examination
- Tone: Hypotonia is common in acute cerebellar lesions; hypertonia suggests other involvement
- Power: Should be normal in pure cerebellar ataxia; weakness suggests additional pathology
- Reflexes: May be normal, pendular (cerebellar), or absent (sensory ataxia, Friedreich ataxia, Miller Fisher syndrome)
- Plantar responses: Extensor (Babinski) suggests corticospinal tract involvement
Sensory Examination
- Proprioception: Joint position sense at toes—abnormal in sensory ataxia, Friedreich ataxia
- Vibration: Using tuning fork at bony prominences—impaired in posterior column dysfunction
- Light touch and pinprick: Usually normal in cerebellar ataxia; abnormal suggests peripheral neuropathy or spinal cord involvement
- Age consideration: Formal sensory testing difficult before age 5-6 years; rely on observation
Examination for Associated Conditions
Musculoskeletal Findings
- Scoliosis: Common in Friedreich ataxia
- Pes cavus (high-arched feet): Friedreich ataxia, hereditary neuropathies
- Hammer toes: Associated with pes cavus
- Contractures: May develop in progressive conditions
Cardiac Examination
- Heart murmur: Hypertrophic cardiomyopathy in Friedreich ataxia
- Rhythm abnormalities: Associated with cardiomyopathy
- Importance: Cardiac involvement is major cause of mortality in Friedreich ataxia
Skin Examination
- Telangiectasias: Conjunctival, ears, flexor surfaces (ataxia-telangiectasia)
- Café-au-lait spots: Neurofibromatosis
- Hypopigmented macules: Tuberous sclerosis
- Icterus: Wilson disease, metabolic disorders
Abdominal Examination
- Hepatomegaly: Wilson disease, storage disorders
- Splenomegaly: Storage disorders, malignancy
- Abdominal mass: Neuroblastoma (associated with opsoclonus-myoclonus)
Expected Findings by Etiology
| Condition | Gait | Limb Coordination | Eye Findings | Reflexes | Other Key Findings |
|---|---|---|---|---|---|
| Acute cerebellar ataxia | Wide-based, ataxic | Dysmetria, intention tremor | Nystagmus possible | Normal | Alert, no focal deficits; may have truncal titubation |
| Drug or toxin ingestion | Ataxic, often unable to walk | Global incoordination | Nystagmus, pupillary changes | Variable (may be depressed) | Altered consciousness, slurred speech, may have specific toxidrome |
| Posterior fossa tumor | Ataxic, may have hemiparesis | May be asymmetric | Papilledema, sixth nerve palsy, nystagmus | May have hyperreflexia | Headache, vomiting, papilledema, head tilt |
| Acute disseminated encephalomyelitis | Ataxic | Variable | Optic neuritis possible | Variable, may have hyperreflexia | Encephalopathy, multifocal signs, fever |
| Friedreich ataxia | Wide-based, progressive | Limb ataxia | Nystagmus (late), no oculomotor apraxia | Absent (areflexia) | Scoliosis, pes cavus, cardiomyopathy, sensory loss |
| Ataxia-telangiectasia | Progressive ataxia | Progressive limb ataxia | Oculomotor apraxia, telangiectasias | Initially normal, may become depressed | Telangiectasias (skin, conjunctiva), choreoathetosis, immunodeficiency |
| Miller Fisher syndrome | Ataxic (sensory component) | Ataxic | Ophthalmoplegia, ptosis | Areflexia | Classic triad: ataxia, ophthalmoplegia, areflexia |
| Opsoclonus-myoclonus syndrome | Ataxic | Ataxic with myoclonus | Opsoclonus (“dancing eyes”) | Usually normal | Myoclonus, irritability, behavioral changes |
| Vestibular disorder | Veers to one side | Usually normal | Horizontal nystagmus (unidirectional) | Normal | Vertigo, nausea, vomiting; worse with head movement |
Important Teaching Point
The examination may be normal in early or mild cases. Some children with acute cerebellar ataxia may show only subtle findings, and some hereditary ataxias have minimal signs early in the disease course. A normal examination does not exclude significant pathology—correlation with history and appropriate investigations is essential. Additionally, examination findings may fluctuate, particularly in episodic ataxias and metabolic disorders. Serial examinations can be valuable.
Examination Pearl: Age-Appropriate Techniques
In young children, formal cerebellar testing is often impossible. Instead, observe the child at play: watch them reach for toys (dysmetria), stack blocks (intention tremor), walk across the room (gait ataxia), and draw or scribble (fine motor). Have them kick a ball or throw at a target. In infants, assess reaching, sitting balance, and head control. The skilled examiner can extract rich cerebellar information from play-based observation without the child realizing they’re being examined.
5. Differential Diagnosis
Systematic approach organized by probability, duration, and clinical features
The differential diagnosis of pediatric ataxia is broad, but a systematic approach based on acuity, age, and associated features allows efficient narrowing of possibilities. Duration of symptoms is the single most important initial discriminator.
Acute Ataxia (Onset less than 72 hours)
Acute ataxia in children requires urgent evaluation to exclude life-threatening causes while recognizing that benign post-infectious ataxia is the most common etiology.
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 70%) | Acute cerebellar ataxia (post-infectious) | Age 2-7 years, preceding viral illness (especially varicella), pure cerebellar syndrome, alert | Altered consciousness suggests alternative diagnosis |
| Drug or toxin ingestion | Toddler age, sudden onset, altered consciousness, pupillary changes, toxidrome | Respiratory depression, severe obtundation, seizures | |
| Vestibular disorders (labyrinthitis, vestibular neuritis) | Vertigo, nausea, vomiting, unidirectional nystagmus, preceding upper respiratory infection | Central nystagmus pattern, other brainstem signs | |
| LESS COMMON (approximately 20%) | Acute disseminated encephalomyelitis | Post-infectious, encephalopathy, multifocal neurological signs, fever | Rapid deterioration, seizures, coma |
| Basilar migraine | Episodic, associated headache, visual symptoms, vertigo, family history | Prolonged symptoms, focal deficits persisting after headache | |
| Post-ictal state | Following witnessed or unwitnessed seizure, transient, improves over hours | Prolonged post-ictal period, focal features | |
| UNCOMMON BUT SERIOUS (approximately 10%) | Posterior fossa stroke | Sudden onset, vomiting, headache, may have cardiac or hematologic risk factors | Altered consciousness, signs of herniation |
| Cerebellar hemorrhage | Sudden severe headache, vomiting, rapid deterioration, may follow trauma or have vascular malformation | Decreasing consciousness, signs of brainstem compression | |
| Bacterial meningitis or cerebellitis | Fever, neck stiffness, ill appearance, may have preceding otitis media | Toxic appearance, petechial rash, altered consciousness | |
| Metabolic crisis | Known metabolic disorder, intercurrent illness trigger, altered consciousness | Acidosis, hyperammonemia, hypoglycemia | |
| Acute hydrocephalus | Headache, vomiting, papilledema, may have known hydrocephalus or shunt | Rapid deterioration, Cushing triad, sixth nerve palsy |
Subacute Ataxia (Onset 72 hours to 4 weeks)
Subacute onset raises concern for structural lesions, inflammatory conditions, and paraneoplastic syndromes. Neuroimaging is essential in this group.
| Probability | Condition | Key Features | Expected Course |
|---|---|---|---|
| COMMON (approximately 50%) | Posterior fossa tumor | Progressive headache (worse in morning), vomiting, personality changes, papilledema, head tilt | Progressive worsening without treatment; requires surgical intervention |
| Resolving acute cerebellar ataxia | Initial acute presentation, now improving, no new symptoms | Gradual improvement over 1-4 weeks; complete recovery expected | |
| LESS COMMON (approximately 35%) | Opsoclonus-myoclonus syndrome | Chaotic eye movements, myoclonic jerks, irritability, ataxia, age 1-3 years | Variable; may relapse; long-term neurodevelopmental sequelae common |
| Miller Fisher syndrome | Preceding infection, triad of ataxia, ophthalmoplegia, areflexia | Monophasic; recovery over weeks to months; generally good prognosis | |
| Cerebellar abscess | Fever, headache, preceding otitis media or sinusitis, focal signs | Requires surgical drainage and antibiotics; may have significant morbidity | |
| UNCOMMON (approximately 15%) | Multiple sclerosis (first presentation) | Older children and adolescents, multifocal symptoms, optic neuritis history | Relapsing-remitting course typical; requires long-term management |
| Autoimmune encephalitis | Behavioral changes, seizures, movement disorders, psychiatric symptoms | Potentially reversible with immunotherapy; may have relapses | |
| Paraneoplastic cerebellar degeneration | Subacute progressive ataxia, may have opsoclonus, search for occult tumor | Variable response to treatment; tumor removal may help |
Chronic Ataxia (Duration greater than 4 weeks)
Step-by-Step Approach to Chronic Ataxia:
- Step 1: Is the ataxia progressive or non-progressive?
- Step 2: For non-progressive — consider congenital or static causes (cerebral palsy, malformations)
- Step 3: For progressive — consider hereditary ataxias, metabolic disorders, slow-growing tumors
- Step 4: For episodic — consider channelopathies, metabolic disorders, migraine variants
- Step 5: Use associated features to narrow diagnosis (areflexia, oculomotor apraxia, cardiomyopathy)
Chronic Non-Progressive Ataxia
| Condition | Age of Recognition | Key Features | Associated Findings |
|---|---|---|---|
| Ataxic cerebral palsy | Infancy to early childhood | Non-progressive, present from early life, hypotonia, delayed motor milestones | May have cognitive impairment, epilepsy; history of perinatal insult in some |
| Dandy-Walker malformation | Infancy | Cerebellar vermis hypoplasia, enlarged fourth ventricle, hydrocephalus | Macrocephaly, developmental delay, may have other CNS anomalies |
| Joubert syndrome | Infancy | “Molar tooth sign” on MRI, hypotonia, ataxia, abnormal breathing patterns | Oculomotor apraxia, renal and retinal abnormalities, developmental delay |
| Cerebellar hypoplasia | Infancy to childhood | Non-progressive ataxia, variable severity | May be isolated or part of syndrome; variable intellectual outcome |
| Sequelae of prior injury | Any age | Static deficits following known insult (stroke, trauma, infection, tumor resection) | History of acute event with subsequent stabilization |
Chronic Progressive Ataxia
| Condition | Typical Onset Age | Inheritance | Key Distinguishing Features |
|---|---|---|---|
| Friedreich ataxia | 5-15 years (before age 25) | Autosomal recessive | Progressive gait and limb ataxia, areflexia, extensor plantars, scoliosis, pes cavus, cardiomyopathy, diabetes |
| Ataxia-telangiectasia | 1-4 years | Autosomal recessive | Progressive ataxia, oculomotor apraxia, telangiectasias, immunodeficiency, elevated alpha-fetoprotein, cancer risk |
| Ataxia with oculomotor apraxia type 1 | 2-10 years | Autosomal recessive | Ataxia, oculomotor apraxia, choreoathetosis, peripheral neuropathy, low albumin, high cholesterol |
| Ataxia with oculomotor apraxia type 2 | 10-22 years | Autosomal recessive | Ataxia, oculomotor apraxia, peripheral neuropathy, elevated alpha-fetoprotein (like ataxia-telangiectasia but no telangiectasias) |
| Spinocerebellar ataxias (various types) | Variable (some in childhood) | Usually autosomal dominant | Progressive ataxia, variable additional features by type (neuropathy, retinopathy, parkinsonism) |
| Mitochondrial disorders | Variable | Mitochondrial or nuclear | Multisystem involvement, ptosis, ophthalmoplegia, myopathy, seizures, stroke-like episodes, elevated lactate |
| Wilson disease | Usually >5 years | Autosomal recessive | Hepatic dysfunction, Kayser-Fleischer rings, psychiatric symptoms, tremor, dystonia |
| Neuronal ceroid lipofuscinoses | Variable by type | Autosomal recessive | Progressive ataxia, seizures, visual loss, cognitive decline, regression |
| Niemann-Pick type C | Variable (childhood to adult) | Autosomal recessive | Ataxia, vertical supranuclear gaze palsy, hepatosplenomegaly, cognitive decline |
| Abetalipoproteinemia | Childhood | Autosomal recessive | Ataxia, retinitis pigmentosa, acanthocytosis, fat malabsorption, very low cholesterol |
Episodic Ataxia
| Condition | Episode Duration | Triggers | Key Features |
|---|---|---|---|
| Episodic ataxia type 1 | Seconds to minutes | Startle, stress, exercise, caffeine | Brief attacks, myokymia between episodes, KCNA1 mutation (potassium channel) |
| Episodic ataxia type 2 | Hours to days | Stress, exertion, caffeine, alcohol | Longer attacks with vertigo and nausea, may develop progressive baseline ataxia, responds to acetazolamide, CACNA1A mutation |
| Basilar migraine | Minutes to hours | Migraine triggers | Associated headache, visual aura, vertigo, family history of migraine |
| Metabolic disorders (intermittent) | Hours to days | Illness, fasting, protein intake | Maple syrup urine disease (intermittent form), organic acidemias, urea cycle disorders; metabolic decompensation |
| Glucose transporter type 1 deficiency | Variable | Fasting, exercise | Seizures, developmental delay, low cerebrospinal fluid glucose, responds to ketogenic diet |
| Pyruvate dehydrogenase deficiency | Variable | Carbohydrate intake | Elevated lactate, developmental delay, may respond to ketogenic diet |
Anatomical Approach to Ataxia
Cerebellar Lesions
Acute cerebellar ataxia
Posterior fossa tumors
Cerebellar stroke or hemorrhage
Cerebellar abscess
Hereditary cerebellar ataxias
Cerebellar malformations
Brainstem Lesions
Brainstem tumors (gliomas)
Demyelination (ADEM, MS)
Encephalitis
Basilar artery stroke
Miller Fisher syndrome
Sensory Pathway Lesions
Peripheral neuropathy
Friedreich ataxia (dorsal columns)
Vitamin B12 deficiency
Miller Fisher syndrome
Guillain-Barré syndrome
Vestibular Lesions
Labyrinthitis
Vestibular neuritis
Benign paroxysmal vertigo of childhood
Vestibular schwannoma (rare in children)
Central vestibular lesions
Drug and Toxin-Induced Ataxia
| Agent Category | Specific Examples | Mechanism | Time to Resolution |
|---|---|---|---|
| Anticonvulsants | Phenytoin, carbamazepine, phenobarbital, valproate, gabapentin, lacosamide | Cerebellar toxicity, sodium channel effects; phenytoin can cause permanent cerebellar atrophy | Hours to days after dose reduction; permanent damage possible with phenytoin |
| Sedatives | Benzodiazepines (diazepam, lorazepam, clonazepam), barbiturates, antihistamines | GABA receptor enhancement, CNS depression | Hours to 1-2 days depending on half-life |
| Alcohol | Ethanol | GABA enhancement, glutamate inhibition, direct cerebellar toxicity | Hours (acute); chronic use may cause permanent damage |
| Lithium | Lithium carbonate | Cerebellar toxicity at high levels | Days to weeks; may be permanent if severe toxicity |
| Solvents and inhalants | Toluene, glue, paint thinner | Direct neurotoxicity, demyelination | Variable; chronic exposure may cause permanent damage |
| Heavy metals | Lead, mercury, thallium | Neuronal toxicity, demyelination | Weeks to months with chelation; may be permanent |
| Chemotherapy | Cytarabine (high-dose), 5-fluorouracil, methotrexate | Direct cerebellar toxicity, particularly Purkinje cells | May be permanent; risk increases with dose and duration |
| Immunosuppressants | Cyclosporine, tacrolimus | Posterior reversible encephalopathy syndrome, direct neurotoxicity | Usually reversible with dose reduction |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Acute ataxia + recent varicella + age 2-7 years | Acute cerebellar ataxia (post-infectious) | MRI to exclude structural lesion; supportive care if confirmed |
| Acute ataxia + altered consciousness + toddler | Drug or toxin ingestion | Toxicology screen, glucose, supportive care, consider antidotes |
| Subacute ataxia + morning headache + vomiting | Posterior fossa tumor | Urgent MRI brain with contrast |
| Ataxia + opsoclonus + myoclonus | Opsoclonus-myoclonus syndrome | Search for neuroblastoma (urine catecholamines, CT/MRI abdomen, MIBG scan) |
| Ataxia + ophthalmoplegia + areflexia | Miller Fisher syndrome | Anti-GQ1b antibodies, lumbar puncture, consider IVIG |
| Progressive ataxia + areflexia + scoliosis + pes cavus | Friedreich ataxia | Genetic testing for FXN GAA expansion, ECG, echocardiogram |
| Progressive ataxia + oculomotor apraxia + telangiectasias | Ataxia-telangiectasia | Alpha-fetoprotein, immunoglobulins, genetic testing for ATM |
| Ataxia + encephalopathy + multifocal neurological signs | Acute disseminated encephalomyelitis | MRI brain and spine, lumbar puncture, consider steroids |
| Episodic ataxia + migraine features + family history | Episodic ataxia type 2 or basilar migraine | Trial of acetazolamide; genetic testing for CACNA1A |
| Ataxia + hepatomegaly + Kayser-Fleischer rings | Wilson disease | Ceruloplasmin, 24-hour urine copper, slit lamp exam |
| Ataxia + vertical gaze palsy + organomegaly | Niemann-Pick type C | Filipin staining, genetic testing |
| Infant with hypotonia + “molar tooth” MRI sign | Joubert syndrome | Genetic testing, renal and ophthalmologic evaluation |
Red Flag Combinations Requiring Emergent Evaluation
- Ataxia + altered consciousness + headache: Consider raised intracranial pressure, hemorrhage, encephalitis
- Ataxia + papilledema: Urgent neuroimaging before lumbar puncture
- Ataxia + signs of herniation: Cushing triad, pupillary changes, posturing—immediate neurosurgical consultation
- Ataxia + respiratory depression: Severe intoxication or brainstem compromise—secure airway
- Ataxia + rapidly ascending weakness: Guillain-Barré spectrum—monitor respiratory function
6. Diagnostic Investigations
A stepwise, clinically-guided approach to investigating pediatric ataxia
The investigation of pediatric ataxia should be guided by the clinical presentation, particularly the acuity and associated features. A stepwise approach prevents unnecessary testing while ensuring serious conditions are not missed.
Baseline Investigations for All Patients with Acute Ataxia
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Blood glucose | Exclude hypoglycemia as cause or complication | Hypoglycemia (less than 3.0 mmol/L or 54 mg/dL) | Point-of-care test; treat immediately if low |
| Electrolytes, urea, creatinine | Metabolic disturbance, dehydration | Hyponatremia, hypernatremia, uremia | Severe disturbances can cause neurological symptoms |
| Complete blood count | Infection, malignancy | Leukocytosis, anemia, thrombocytopenia, blasts | Leukemia can present with neurological symptoms |
| Liver function tests | Hepatic encephalopathy, metabolic disease | Elevated transaminases, ammonia | Add ammonia if altered consciousness |
| Toxicology screen | Drug or toxin ingestion | Benzodiazepines, anticonvulsants, alcohols, other drugs | Blood and urine; consider extended panel; serum osmolar gap for toxic alcohols |
| Anticonvulsant drug levels | Toxicity in patients on these medications | Phenytoin greater than 80 μmol/L (20 μg/mL), carbamazepine greater than 50 μmol/L (12 μg/mL) | Check in any patient on anticonvulsants presenting with ataxia |
| MRI brain (with contrast) | Structural lesion, inflammation, hemorrhage | Tumor, stroke, demyelination, malformation, hemorrhage | Essential in acute ataxia; CT if MRI unavailable or for emergency assessment |
Imaging Considerations in Children
- MRI is preferred over CT for posterior fossa imaging due to superior resolution and no radiation
- CT may be used emergently if raised intracranial pressure or hemorrhage is suspected and MRI is not immediately available
- Sedation or general anesthesia may be required for MRI in young children—plan accordingly
- Contrast enhancement is important for detecting tumors, abscesses, and inflammatory conditions
- Include posterior fossa protocol with thin cuts through cerebellum and brainstem
Targeted Investigations by Suspected Etiology
If Suspecting Post-Infectious Acute Cerebellar Ataxia
First-Line Tests
- MRI brain: May be normal or show mild cerebellar swelling; excludes structural lesions
- Clinical diagnosis: Primarily based on history of preceding infection, age 2-7 years, pure cerebellar syndrome, normal consciousness
Second-Line Tests (if atypical features)
- Lumbar puncture: May show mild pleocytosis; rule out encephalitis if encephalopathy present
- Viral serologies: Varicella zoster virus, Epstein-Barr virus, Mycoplasma pneumoniae, enterovirus
- Autoimmune encephalitis antibodies: If behavioral changes or seizures
If Suspecting Drug or Toxin Ingestion
First-Line Tests
- Comprehensive toxicology screen: Blood and urine
- Serum osmolality and osmolar gap: Elevated gap suggests toxic alcohols (methanol, ethylene glycol)
- Blood gas: Metabolic acidosis in toxic alcohol ingestion
- Specific drug levels: Phenytoin, carbamazepine, ethanol, salicylate, acetaminophen
Additional Considerations
- ECG: QRS widening (tricyclics), QTc prolongation (various drugs)
- Blood lead level: If chronic exposure suspected
- Heavy metal screen: Mercury, thallium if indicated by history
- Contact poison control center for guidance on specific ingestions
If Suspecting Posterior Fossa Tumor
Essential Tests
- MRI brain with contrast: Defines tumor location, size, enhancement pattern, hydrocephalus
- MRI spine with contrast: Staging for medulloblastoma and other tumors that can seed
- Lumbar puncture for cytology: After relieving hydrocephalus if present; for staging
Additional Workup
- Tumor markers: Alpha-fetoprotein and beta-hCG for germ cell tumors
- Pre-operative evaluation: As directed by neurosurgery
- Ophthalmology evaluation: Papilledema assessment
If Suspecting Opsoclonus-Myoclonus Syndrome
Neuroblastoma Search (Critical)
- Urine catecholamines: Homovanillic acid and vanillylmandelic acid (elevated in 90% of neuroblastoma)
- CT or MRI abdomen and pelvis: Adrenal and paraspinal tumors
- MIBG scan: Meta-iodobenzylguanidine scan for neuroblastoma detection
- Chest radiograph or CT: Mediastinal neuroblastoma
Additional Evaluation
- MRI brain: Usually normal; excludes other pathology
- Lumbar puncture: May show pleocytosis; oligoclonal bands possible
- Repeat tumor surveillance: If initial workup negative, repeat in 3-6 months
If Suspecting Miller Fisher Syndrome
Diagnostic Tests
- Anti-GQ1b antibodies: Positive in greater than 85% of cases; highly specific
- Lumbar puncture: Albuminocytologic dissociation (elevated protein, normal cells)—may be normal early
- Nerve conduction studies: May show sensory abnormalities
Monitoring
- Respiratory function: Forced vital capacity, as overlap with Guillain-Barré syndrome possible
- MRI brain: To exclude brainstem pathology
- Serial neurological examination: For disease progression
If Suspecting Friedreich Ataxia
Diagnostic Tests
- Genetic testing: GAA trinucleotide repeat expansion in FXN gene (diagnostic)
- Nerve conduction studies: Axonal sensory neuropathy
- MRI brain and spine: Cervical spinal cord atrophy; cerebellum often normal early
Systemic Evaluation
- ECG: T-wave inversions, ventricular hypertrophy
- Echocardiogram: Hypertrophic cardiomyopathy (present in majority)
- Fasting glucose and HbA1c: Diabetes screening (10-30% develop diabetes)
- Audiology: Hearing assessment
If Suspecting Ataxia-Telangiectasia
Diagnostic Tests
- Alpha-fetoprotein: Elevated in greater than 95% (usually greater than 10 times normal)
- Immunoglobulin levels: Low IgA, IgG subclasses; IgM may be elevated
- Lymphocyte subsets: Reduced T-cells
- Genetic testing: ATM gene mutations
Additional Considerations
- Chromosomal breakage studies: Increased sensitivity to radiation
- MRI brain: Cerebellar atrophy
- Cancer surveillance: Increased lymphoma and leukemia risk
- Avoid unnecessary radiation: Due to radiosensitivity
If Suspecting Metabolic Disorder
Screening Tests
- Blood lactate and pyruvate: Mitochondrial disorders, pyruvate metabolism defects
- Ammonia: Urea cycle disorders, organic acidemias
- Plasma amino acids: Maple syrup urine disease, homocystinuria
- Urine organic acids: Organic acidemias
- Acylcarnitine profile: Fatty acid oxidation defects
Specific Tests
- Very long chain fatty acids: Peroxisomal disorders
- Ceruloplasmin and serum copper: Wilson disease
- 24-hour urine copper: Wilson disease
- Vitamin E level: Ataxia with vitamin E deficiency
- Cholesterol and lipid profile: Abetalipoproteinemia, cerebrotendinous xanthomatosis
Lumbar Puncture: When and Why
| Indication | What to Order | Expected Findings |
|---|---|---|
| Suspected meningitis or encephalitis | Cell count, protein, glucose, Gram stain, culture, viral PCR panel (HSV, enterovirus, VZV) | Pleocytosis, elevated protein, low glucose (bacterial); lymphocytic pleocytosis (viral) |
| Acute disseminated encephalomyelitis | Cell count, protein, glucose, oligoclonal bands, myelin basic protein | Mild pleocytosis, mildly elevated protein; oligoclonal bands in some |
| Miller Fisher syndrome | Cell count, protein | Albuminocytologic dissociation (high protein, normal cells)—may be normal early |
| Opsoclonus-myoclonus syndrome | Cell count, protein, oligoclonal bands | Mild pleocytosis possible; oligoclonal bands suggest immune-mediated process |
| Glucose transporter type 1 deficiency | CSF glucose (with simultaneous blood glucose), CSF lactate | CSF glucose less than 60% of blood glucose; low CSF lactate |
| CNS tumor staging | Cytology | Malignant cells indicate leptomeningeal spread |
Important: Contraindications to Lumbar Puncture
Perform neuroimaging BEFORE lumbar puncture if:
- Signs of raised intracranial pressure (papilledema, bulging fontanelle, Cushing triad)
- Focal neurological deficits
- Altered consciousness
- Suspected posterior fossa mass lesion
Lumbar puncture in the presence of a mass lesion or raised intracranial pressure risks herniation.
Genetic Testing Approach
| Clinical Scenario | Recommended Genetic Test | Comments |
|---|---|---|
| Progressive ataxia with areflexia, scoliosis, pes cavus | FXN gene GAA repeat analysis (Friedreich ataxia) | Most common inherited ataxia; repeat expansion testing is first-line |
| Progressive ataxia with oculomotor apraxia and telangiectasias | ATM gene sequencing (ataxia-telangiectasia) | Confirm after elevated alpha-fetoprotein; important for cancer surveillance |
| Progressive ataxia with oculomotor apraxia, no telangiectasias | AOA1 (APTX) and AOA2 (SETX) gene analysis | Distinguish from ataxia-telangiectasia; check albumin (low in AOA1) |
| Episodic ataxia responding to acetazolamide | CACNA1A gene (episodic ataxia type 2) | Also associated with familial hemiplegic migraine and SCA6 |
| Episodic ataxia with myokymia | KCNA1 gene (episodic ataxia type 1) | Potassium channel gene; episodes brief (seconds to minutes) |
| Infantile-onset ataxia with “molar tooth” MRI | Joubert syndrome gene panel (multiple genes) | Ciliopathy; also evaluate kidneys and retina |
| Progressive ataxia with unclear etiology | Ataxia gene panel or whole exome sequencing | Comprehensive panels include 100+ ataxia-related genes |
| Family history of autosomal dominant ataxia | Spinocerebellar ataxia repeat panel (SCA1, 2, 3, 6, 7, etc.) | Trinucleotide repeat expansions; anticipation may occur |
Investigation Algorithm by Duration
Acute Ataxia (less than 72 hours):
- Glucose, electrolytes, complete blood count, liver function tests
- Toxicology screen and anticonvulsant levels (if applicable)
- MRI brain with contrast (or CT if MRI not immediately available)
- Lumbar puncture if infection suspected (after imaging if indicated)
- Consider: viral serologies, autoimmune encephalitis panel
Subacute Ataxia (72 hours to 4 weeks):
- All acute workup as above
- MRI brain AND spine with contrast (essential)
- If opsoclonus-myoclonus: urine catecholamines, CT/MRI abdomen, MIBG scan
- If ophthalmoplegia and areflexia: anti-GQ1b antibodies, nerve conduction studies
- Consider: tumor markers, lumbar puncture for cytology if tumor identified
Chronic Progressive Ataxia (greater than 4 weeks):
- MRI brain and spine
- Alpha-fetoprotein (elevated in ataxia-telangiectasia and AOA2)
- Genetic testing: FXN gene first if areflexia present; ataxia panel or exome if negative
- Metabolic screen: lactate, ammonia, amino acids, organic acids, ceruloplasmin, vitamin E
- ECG and echocardiogram (Friedreich ataxia cardiomyopathy)
- Nerve conduction studies
- Immunoglobulin levels (if ataxia-telangiectasia suspected)
Investigation Pearl: The Value of Serial Assessment
In pediatric ataxia, a single set of investigations may not provide the diagnosis. Serial clinical assessment is often as valuable as testing. A child diagnosed with “acute cerebellar ataxia” who does not improve as expected should have repeat imaging and expanded workup. Similarly, in episodic ataxia, capturing investigations during an episode (including video of symptoms) can be diagnostically valuable. For opsoclonus-myoclonus syndrome with initially negative tumor workup, repeat neuroblastoma screening every 3-6 months for at least 2 years is recommended.
7. Clinical Decision-Making
Practical algorithms and decision pathways for pediatric ataxia
Step 1: Is This Urgent?
The first priority in evaluating a child with ataxia is to identify those requiring emergent intervention. Use the following triage framework:
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Altered consciousness with ataxia | EMERGENT | Stabilize airway, breathing, circulation; glucose check; toxicology screen; urgent CT head; prepare for possible intubation |
| Signs of raised intracranial pressure (papilledema, bulging fontanelle, Cushing triad, sixth nerve palsy) | EMERGENT | Urgent CT head; neurosurgical consultation; elevate head of bed; avoid lumbar puncture until imaging reviewed |
| Suspected severe intoxication with respiratory depression | EMERGENT | Secure airway; antidotes if available (naloxone, flumazenil with caution); toxicology; supportive care |
| Rapidly progressive weakness with ataxia | EMERGENT | Monitor respiratory function (forced vital capacity); prepare for possible respiratory failure; consider Guillain-Barré spectrum |
| Fever with neck stiffness and ataxia | EMERGENT | Blood cultures; empiric antibiotics; CT before LP if focal signs; lumbar puncture when safe |
| Acute ataxia with headache and vomiting | URGENT | MRI brain with contrast within hours; fundoscopy; monitor for deterioration |
| Opsoclonus-myoclonus identified | URGENT | Urgent tumor workup (urine catecholamines, imaging) as neuroblastoma may be present; pediatric oncology involvement |
| New ataxia with ophthalmoplegia and areflexia | URGENT | Admit for monitoring; anti-GQ1b antibodies; watch for respiratory compromise; consider IVIG |
| Acute ataxia, alert, no red flags, preceding viral illness | SEMI-URGENT | MRI brain within 24-48 hours to exclude structural lesion; if imaging normal and classic presentation, likely acute cerebellar ataxia |
| Chronic progressive ataxia, stable | ROUTINE | Outpatient workup appropriate; MRI, genetic testing, metabolic studies as indicated; pediatric neurology referral |
Step 2: Classify by Duration
Acute (less than 72 hours)
Proceed to Algorithm A
Focus on excluding emergencies, toxins, and infections
Subacute (72 hours to 4 weeks)
Proceed to Algorithm B
High suspicion for structural lesions; imaging essential
Chronic (greater than 4 weeks)
Proceed to Algorithm C
Distinguish progressive from non-progressive; genetic and metabolic workup
Step 3: Follow the Appropriate Algorithm
Algorithm A: Acute Ataxia
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Toddler, acute onset, altered consciousness, possible access to medications | Drug or toxin ingestion | Toxicology screen, supportive care, consider antidotes, contact poison control |
| Age 2-7 years, varicella or viral illness 1-3 weeks ago, alert, pure cerebellar syndrome | Acute cerebellar ataxia (post-infectious) | MRI to exclude structural lesion; if normal, supportive care and observation; excellent prognosis |
| Acute vertigo, nausea, unidirectional nystagmus, recent upper respiratory infection | Vestibular neuritis or labyrinthitis | Symptomatic treatment; differentiate from central causes; MRI if atypical features |
| Encephalopathy with multifocal signs, post-infectious | Acute disseminated encephalomyelitis | MRI brain and spine; high-dose corticosteroids; IVIG or plasmapheresis if steroid-refractory |
| Headache with ataxia, visual symptoms, family history of migraine | Basilar migraine | MRI to exclude structural cause; abortive and prophylactic migraine treatment |
| Known epilepsy, recent seizure, transient ataxia improving over hours | Post-ictal ataxia | Observation; ensure anticonvulsant compliance; consider EEG if new seizure type |
Algorithm B: Subacute Ataxia
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Progressive headache (worse mornings), vomiting, papilledema, personality change | Posterior fossa tumor | Urgent MRI with contrast; neurosurgical consultation; manage hydrocephalus if present |
| Chaotic eye movements (opsoclonus), myoclonic jerks, irritability, age 1-3 years | Opsoclonus-myoclonus syndrome | Full neuroblastoma workup (urine catecholamines, CT/MRI abdomen, MIBG); immunotherapy |
| Ataxia with ophthalmoplegia and areflexia, preceding infection | Miller Fisher syndrome | Anti-GQ1b antibodies; monitor respiratory function; consider IVIG; usually good recovery |
| Fever, headache, preceding otitis media or sinusitis | Cerebellar abscess | MRI with contrast; neurosurgical drainage; prolonged antibiotics; ENT evaluation |
| Adolescent with multifocal symptoms, optic neuritis history | Multiple sclerosis (first presentation) | MRI brain and spine with contrast; lumbar puncture (oligoclonal bands); neurology referral |
Algorithm C: Chronic Ataxia
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Non-progressive since early childhood, hypotonia, delayed milestones, no regression | Ataxic cerebral palsy or congenital cerebellar malformation | MRI to characterize anatomy; genetic testing if dysmorphic or syndromic; rehabilitation focus |
| Progressive ataxia, onset 5-15 years, areflexia, scoliosis, pes cavus | Friedreich ataxia | FXN gene testing; ECG and echocardiogram; glucose screening; multidisciplinary care |
| Progressive ataxia, onset 1-4 years, oculomotor apraxia, telangiectasias, recurrent infections | Ataxia-telangiectasia | Alpha-fetoprotein; immunoglobulins; ATM gene testing; avoid radiation; cancer surveillance |
| Episodic ataxia lasting hours, triggered by stress or exertion, responds to acetazolamide | Episodic ataxia type 2 | Trial of acetazolamide; CACNA1A genetic testing; monitor for progressive baseline ataxia |
| Progressive ataxia with hepatomegaly, psychiatric symptoms, tremor | Wilson disease | Ceruloplasmin, 24-hour urine copper, slit lamp for Kayser-Fleischer rings; liver biopsy if needed |
| Progressive ataxia with seizures, visual loss, cognitive decline | Neuronal ceroid lipofuscinosis or other storage disorder | MRI (atrophy pattern); ERG; enzyme studies; genetic testing; palliative care planning |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| MRI shows posterior fossa mass | Urgent neurosurgical consultation; assess for hydrocephalus; dexamethasone if significant edema | Surgical planning; staging workup (spine MRI, CSF cytology post-operatively) |
| Toxicology screen positive for benzodiazepines | Supportive care; monitor airway and respiratory status; flumazenil only if severe and no seizure risk | Social work involvement; determine source of ingestion; safety planning |
| Child improving from acute cerebellar ataxia but not yet normal | Reassurance; recovery takes 1-4 weeks typically | Follow-up in 2-4 weeks; if no improvement by 4 weeks, reconsider diagnosis |
| Acute cerebellar ataxia not improving at 4 weeks | Repeat MRI; expand workup | Consider: slowly progressive cause missed initially, autoimmune cerebellitis, metabolic disorder |
| Opsoclonus-myoclonus but tumor workup negative | Begin immunotherapy anyway (steroids, IVIG); close monitoring | Repeat tumor surveillance every 3-6 months for at least 2 years; neuroblastoma may become apparent later |
| Friedreich ataxia confirmed genetically | Cardiac evaluation (ECG, echocardiogram); diabetes screening; audiology | Multidisciplinary clinic; physical therapy; monitor for cardiomyopathy; discuss prognosis and emerging therapies |
| Ataxia-telangiectasia confirmed | Immunology evaluation; establish infection prophylaxis if needed | Cancer surveillance; avoid unnecessary radiation; immunoglobulin replacement if indicated; family genetic counseling |
| Family asks about prognosis in progressive hereditary ataxia | Honest, compassionate discussion; connect with support resources | Genetic counseling for family; discuss clinical trials if available; palliative care involvement for advanced cases |
| Suspected functional ataxia (inconsistent examination, normal workup) | Avoid dismissive language; acknowledge symptoms are real | Psychology or psychiatry referral; physical therapy; identify and address stressors; avoid unnecessary testing |
Troubleshooting: When the Diagnosis Remains Unclear
Ask These Questions
- Is the history complete? Re-interview family; speak with the child privately if adolescent; contact school or other caregivers
- Was the examination thorough? Repeat examination; have a colleague examine; consider video recording of gait
- Is the duration accurately characterized? Subtle symptoms may have been present longer than initially reported
- Were investigations adequate? Consider repeat MRI with different sequences; expand metabolic and genetic testing
- Could this be functional? Look for inconsistencies; Hoover sign; distractibility; psychological stressors
- Is specialist input needed? Pediatric neurology, genetics, metabolic medicine, neuro-ophthalmology
- Should empiric treatment be tried? Trial of acetazolamide for suspected episodic ataxia; vitamins for suspected deficiency
- Is watchful waiting appropriate? Serial examinations and repeat investigations may clarify evolving conditions
When to Refer to Pediatric Neurology
Urgent Referral (Same Day)
- Any acute ataxia with red flags
- Suspected posterior fossa tumor
- Opsoclonus-myoclonus syndrome
- Rapidly progressive symptoms
- Acute disseminated encephalomyelitis
Routine Referral (Within Weeks)
- Chronic progressive ataxia for workup
- Episodic ataxia for evaluation
- Confirmed hereditary ataxia for management
- Congenital ataxia for rehabilitation planning
- Ataxia not resolving as expected
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from experience and avoid common mistakes
Must-Know Clinical Pearls
The “Big Four” dominate acute presentations: Acute cerebellar ataxia (post-infectious), drug or toxin ingestion, posterior fossa tumor, and acute disseminated encephalomyelitis account for the vast majority of acute ataxia in children. A systematic approach targeting these four will capture most cases.
Always consider ingestion in toddlers: In any toddler with acute ataxia, drug or toxin ingestion must be high on the differential, even if caregivers deny the possibility. Check grandparents’ medications, older siblings’ medications, household chemicals, and plants.
MRI before diagnosis of acute cerebellar ataxia: Even when the history is classic for post-infectious acute cerebellar ataxia, obtain MRI to exclude a posterior fossa tumor. The clinical presentations can overlap, and missing a tumor has devastating consequences.
Opsoclonus demands neuroblastoma search: When you see opsoclonus (chaotic, multidirectional eye movements), immediately think neuroblastoma. Even if initial tumor workup is negative, repeat surveillance every 3-6 months for at least 2 years—the tumor may become apparent later.
Areflexia is a key discriminator: In progressive ataxia, the presence of areflexia strongly suggests Friedreich ataxia (combined cerebellar and sensory ataxia) or Miller Fisher syndrome. Check reflexes carefully—this finding significantly narrows the differential.
Alpha-fetoprotein is a powerful screening test: Elevated alpha-fetoprotein is found in over 95% of patients with ataxia-telangiectasia and in ataxia with oculomotor apraxia type 2. This simple blood test can direct your workup in progressive ataxia.
Friedreich ataxia requires cardiac surveillance: Hypertrophic cardiomyopathy occurs in the majority of Friedreich ataxia patients and is a leading cause of death. Every confirmed patient needs baseline ECG and echocardiogram with regular follow-up.
Episodic ataxia often responds to acetazolamide: If you suspect episodic ataxia type 2 (attacks lasting hours, triggered by stress or exertion), a therapeutic trial of acetazolamide can be both diagnostic and therapeutic while genetic testing is pending.
Critical Pitfalls to Avoid
Diagnosing acute cerebellar ataxia without imaging: Never diagnose “benign” post-infectious acute cerebellar ataxia without MRI. Posterior fossa tumors can present identically, and the consequences of missing a tumor are severe. MRI is mandatory.
Attributing ataxia to “viral illness” without evaluation: While post-infectious ataxia is common, this is a diagnosis of exclusion. Do not simply observe a child with ataxia based on recent illness without appropriate workup including imaging.
Performing lumbar puncture before imaging in ataxia with headache: Ataxia combined with headache may indicate a posterior fossa mass with raised intracranial pressure. Lumbar puncture in this setting risks herniation. Always image first.
Missing ingestion because caregivers deny it: Caregivers may not know about an ingestion, may not realize a substance is toxic, or may be reluctant to disclose. Always check toxicology in acute ataxia, regardless of history.
Stopping neuroblastoma surveillance after one negative workup: In opsoclonus-myoclonus syndrome, neuroblastoma may not be detectable at initial presentation. Negative workup does not exclude tumor—repeat surveillance is essential.
Forgetting about phenytoin toxicity and chronic cerebellar damage: Phenytoin can cause permanent cerebellar atrophy with chronic use, even at therapeutic levels. Check levels in any patient on phenytoin presenting with ataxia, and consider this as a cause of “unexplained” progressive ataxia.
Overlooking ataxia-telangiectasia because telangiectasias are absent: Telangiectasias typically appear between ages 3-6 years. In younger children, ataxia-telangiectasia may present with ataxia before the characteristic skin findings develop. Check alpha-fetoprotein.
Ordering unnecessary radiation in suspected ataxia-telangiectasia: Patients with ataxia-telangiectasia have extreme sensitivity to ionizing radiation due to defective DNA repair. Minimize CT scans and avoid radiotherapy when this diagnosis is suspected.
Key Takeaways
- Duration is your guide: Classify ataxia as acute, subacute, or chronic first—this immediately narrows the differential and determines urgency.
- Acute ataxia requires exclusion of emergencies: Toxin ingestion, posterior fossa mass, hemorrhage, and infection must be ruled out before diagnosing benign causes.
- MRI is essential: In virtually all cases of new-onset ataxia, MRI brain (and often spine) with contrast is required to exclude structural pathology.
- Post-infectious acute cerebellar ataxia has an excellent prognosis: Once serious causes are excluded, most children with acute cerebellar ataxia recover completely within 1-4 weeks.
- Subacute onset demands tumor exclusion: Progressive ataxia over days to weeks has a high likelihood of representing a posterior fossa tumor until proven otherwise.
- Opsoclonus-myoclonus syndrome requires prolonged tumor surveillance: Search for neuroblastoma at diagnosis and continue surveillance for at least 2 years even if initial workup is negative.
- In progressive ataxia, think Friedreich ataxia first: It is the most common inherited ataxia; areflexia, scoliosis, and pes cavus are classic clues. Don’t forget the cardiac evaluation.
- Alpha-fetoprotein and oculomotor apraxia point to specific diagnoses: Elevated alpha-fetoprotein suggests ataxia-telangiectasia or ataxia with oculomotor apraxia type 2. Oculomotor apraxia (needing head thrusts to shift gaze) is seen in ataxia-telangiectasia, Joubert syndrome, and ataxia with oculomotor apraxia types 1 and 2.
- Episodic ataxia is often treatable: Acetazolamide can dramatically reduce attacks in episodic ataxia type 2. Consider a therapeutic trial in appropriate cases.
- Multidisciplinary care improves outcomes: Children with chronic ataxia benefit from coordination between neurology, cardiology, genetics, physical therapy, occupational therapy, and speech therapy.
Quick Reference Algorithm
Systematic Approach to Pediatric Ataxia:
- Assess urgency: Is the child stable? Any signs of raised intracranial pressure, altered consciousness, or respiratory compromise? If yes, emergent management first.
- Determine duration: Acute (less than 72 hours), subacute (72 hours to 4 weeks), or chronic (greater than 4 weeks)?
- Identify the ataxia type: Cerebellar (wide-based gait, dysmetria, nystagmus), sensory (positive Romberg, proprioceptive loss), or vestibular (vertigo, directional nystagmus)?
- Perform baseline investigations: Glucose, electrolytes, complete blood count, toxicology screen, and MRI brain with contrast for all acute and subacute presentations.
- Look for associated features: Altered consciousness (toxins, raised intracranial pressure), opsoclonus (neuroblastoma), ophthalmoplegia and areflexia (Miller Fisher syndrome), scoliosis and areflexia (Friedreich ataxia), telangiectasias and oculomotor apraxia (ataxia-telangiectasia).
- Target investigations to suspected etiology: Tumor markers, anti-GQ1b antibodies, alpha-fetoprotein, genetic testing, metabolic studies as indicated.
- Exclude serious diagnoses before diagnosing benign conditions: Acute cerebellar ataxia is a diagnosis of exclusion—MRI must be performed.
- Arrange appropriate follow-up: For acute cerebellar ataxia, follow up in 2-4 weeks to confirm recovery. For chronic ataxia, establish multidisciplinary care.
- Consider referral: Pediatric neurology for all cases of subacute or chronic ataxia, atypical presentations, and cases not improving as expected.
- Support the family: Provide clear information, connect with support resources, and address the emotional impact of the diagnosis.